Loading...

Emerging Epidemics: Management and Control

ISBN: 978-1-118-39325-3

June 2013

Wiley-Blackwell

760 pages

Description

A global perspective on the management and prevention of emerging and re-emerging diseases

Emerging infectious diseases are newly identified or otherwise previously unknown infections that cause public health challenges. Re-emerging infectious diseases are due to both the reappearance of and an increase in the number of infections from a disease that is known, but which had formerly caused so few infections that it was no longer considered a public health problem. The factors that cause the emergence or re-emergence of a disease are diverse.

This book takes a look at the world's emerging and re-emerging diseases. It covers the diagnosis, therapy, prevention, and control of a variety of individual diseases, and examines the social and behavioral issues that could contribute to epidemics. Each chapter focuses on an individual disease and provides scientific background and social history as well as the current basics of infection, epidemiology, and control.

Emerging Epidemics: Management and Control offers five topics of coverage:

FUNDAMENTALS

  • Epidemics fundamentals
  • Disasters and epidemics
  • Biosafety

RE-EMERGING EPIDEMICS

  • Tuberculosis
  • Plague

NEWLY EMERGING EPIDEMICS

  • Leptospirosis
  • Dengue
  • Japanese Encephalitis
  • Chikungunya Fever
  • West Nile Virus
  • Chandipura Virus Encephalitis
  • Kyasanur Forest Disease
  • Hantavirus
  • Human, Avian, and Swine Influenza
  • Severe Acute Respiratory Syndrome
  • Nipah Virus
  • Paragonimiasis
  • Melioidosis

POTENTIAL EPIDEMICS

  • Biowarfare and bioterrorism
  • Food contamination and food terrorism
  • Antimicrobial resistance

VECTOR CONTROL METHODS

  • Mosquito control
  • Other disease vectors and their control

Offering an integrated, worldwide overview of the complexity of the epidemiology of infections, Emerging Epidemics will be a valuable resource for students, physicians, and scientists working in veterinary, medical, and the pharmaceutical sciences.

About the Author

Prakash Singh Bisen, PhD, D.Sc, is an eminent scientist in the field of Biotechnology with over 32 years of research and teaching experience. He has one US Patent and an Indian Patent on Tuberculosis to his credit. He is also an author of over 130 research publications. Presently, Professor Bisen is the Chairman of Bisen Biotech and Biopharma (P) Ltd. — a private equity venture which focuses on diagnostic solutions for widespread diseases. Professor Bisen is also the Chairman of the Vikrant Group, which focuses on advancing technical education through technical institutes at Gwalior and Indore, India.

Ruchika Raghuvanshi, PhD, is a Research Scientist at the Defence Research Development Organization, a division of the Indian Ministry of Defence.

Vijayaraghavan, PhD, is Director of the Defence Research Development Establishment, the Defence Research Development Organization, a division of the Indian Ministry of Defence.